Celsion Corporation Stock News

Celsion Corporation (CLSN) with the stream of -5.25% also noticed, India Evolve Transition Infrastructure LP (SNMP) encountered a rapid change of -4.87% in the last hour of Fridays trading session. The post Latest Tally Of Analyst Opinions: Celsion Corporation (NASDAQ:CLSN), Evolve Transition Infrastructure LP (AMEX:SNMP) appeared first on Stocks Equity .

Equities research analysts expect Celsion Co. (NASDAQ:CLSN) to post $120,000.00 in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Celsions earnings. The highest sales estimate is $130,000.00 and the lowest is $100,000.00. Celsion reported sales of $130,000.00 in the same quarter last year, which indicates a negative year over []

Outlook Therapeutics, Inc. (OTLK) with the stream of -4.22% also noticed, India Celsion Corporation (CLSN) encountered a rapid change of -2.68% in the last hour of Monday’s trading session. Outlook … The post Comparable Company Analysis: Outlook Therapeutics, Inc. (NASDAQ:OTLK), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .

Vanguard Group Inc. raised its holdings in Celsion Co. (NASDAQ:CLSN) by 17.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,678,489 shares of the biotechnology companys stock after acquiring an additional 555,877 shares during the period. Vanguard Group Inc.s holdings in Celsion were worth $4,672,000 at []

Artelo Biosciences, Inc. (ARTL) with the stream of -3.73% also noticed, India Celsion Corporation (CLSN) encountered a rapid change of -0.54% in the last hour of Fridays trading session. Artelo The post Valuing Stock Using Ratios and Multiples: Artelo Biosciences, Inc. (NASDAQ:ARTL), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .

Celsion Corporation (CLSN) with the stream of -3.48% also noticed, India PolarityTE, Inc. (PTE) encountered a rapid change of 0.70% in the last hour of Tuesdays trading session. Celsion Corporation The post Up to Date Trending Stock: Celsion Corporation (NASDAQ:CLSN), PolarityTE, Inc. (NASDAQ:PTE) appeared first on Stocks Equity .

Celsion (NASDAQ:CLSN) issued its quarterly earnings data on Monday. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts consensus estimates of ($0.08) by $0.02, MarketWatch Earnings reports. Celsion had a negative return on equity of 50.81% and a negative net margin of 4,444.40%. During the same quarter in the prior []

Celsion Corporation (CLSN) CEO Michael Tardugno on Q3 2021 Results - Earnings Call Transcript

Balance Sheet Supports Focus o n Immuno-Oncology and Next-Generation Vaccine Initiative

Brokerages expect Celsion Co. (NASDAQ:CLSN) to post ($0.08) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Celsions earnings, with the highest EPS estimate coming in at ($0.06) and the lowest estimate coming in at ($0.11). Celsion reported earnings per share of ($0.17) during the []

LAWRENCEVILLE, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation  (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, annou

Chief Science Officer Dr. Khursheed Anwer to D eliver V irtual P resentation Monday, October 18 at 7:30 a.m. Eastern Time

The stock price of Celsion Corporation (NASDAQ: CLSN) increased from $0.88 on Thursday to about $0.95-$1 today. This is why it happened.

Chief Science Officer Dr. Khursheed Anwer to D eliver V irtual P resentation on Celsion's O ngoing W ork with DNA-based V accines